1-9 of 9
Dina Schneider, PhD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A Fully-Human Armored BCMA CAR Boosts Function of CD4 + CAR-T Cells and Resists TGF-β Suppression in Pre-Clinical Models of Multiple Myeloma

Leah Alabanza, PhD, Bang Vu, PhD, Darong Wu, MS, Zhongyu Zhu, PhD, Boro Dropulic, PhDMBA, Dina Schneider, PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 37–38.
https://doi.org/10.1182/blood-2020-141062
Published: 2020
Journal Articles

Fully Human Tandem CD22-CD19 CAR-T Cells with Superior Sensitivity to Low Antigen Density Derived by Optimization of Co-Stimulation and CAR Architecture

Peirong Hu, PhD, Ying Xiong, PhD, Darong Wu, MS, Zhongyu Zhu, PhD, Boro Dropulic, PhDMBA, Dina Schneider, PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 12–13.
https://doi.org/10.1182/blood-2020-140836
Published: 2020
Journal Articles

Single-Cell RNA Sequencing Identifies Expression Patterns Associated with Clinical Responses to Dual-Targeted CAR-T Cell Therapy

Tyce Kearl, MD PhD, Ao Mei, Ryan Brown, Bryon Johnson, PhD, Dina Schneider, PhD, Boro Dropulic, PhDMBA, Parameswaran Hari, MD MRCP, Nirav N. Shah, MD, Subramaniam Malarkannan, PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 33–34.
https://doi.org/10.1182/blood-2020-142937
Published: 2020
Journal Articles

Single-Cell Cytokine Analysis of LV20.19 Bispecific CAR T-Cell Products from a Phase I Clinical Trial

Huiqing Xu, MD, Katherine Chaney, MS, Bryon Johnson, PhD, Timothy S. Fenske, MD, Mehdi Hamadani, MD, Boro Dropulic, PhDMBA, Dina Schneider, PhD, Parameswaran Hari, MD MRCP, Nirav N. Shah, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 22.
https://doi.org/10.1182/blood-2020-136805
Published: 2020
Journal Articles

Phase 1 Study of on Site Manufactured Anti-CD19 CAR-T Cells: Responses in Subjects with Rapidly Progressive Refractory Lymphomas

Paolo F Caimi, MD, Jane Reese, Folashade Otegbeye, MBBChir,MPH, Dina Schneider, PhD, Kristen Bakalarz, CNP, Kirsten M Boughan, DO, Brenda Cooper, MD, Molly M Gallogly, MD PhD, Erin Galloway, RN BSN, Winfried Kruger, Andrew Worden, Michael Kadan, Filipa Blasco Lopes, Ashish Sharma, Ehsan Malek, MD, Leland Metheny, III, MD, Seema Patel, PharmD, Benjamin K. Tomlinson, MD, David Wald, MD PhD, Rafick-Pierre Sekaly, Rimas Orentas, PhD, Boro Dropulic, PhD, Marcos de Lima, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 4074.
https://doi.org/10.1182/blood-2019-131300
Published: 2019
Journal Articles

Fresh Versus Cryopreserved/Thawed Bispecific Anti-CD19/CD20 CAR-T Cells for Relapsed, Refractory Non-Hodgkin Lymphoma

Nirav N. Shah, MD, Fenlu Zhu, PhD, Dina Schneider, PhD, Winfried Krueger, Andrew Worden, Walter L. Longo, MD, Mehdi Hamadani, MD, Timothy S. Fenske, MD, Boro Dropulic, PhD, Rimas J Orentas, PhD, Parameswaran Hari, MBBS, MD, Bryon Johnson, PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 4465.
https://doi.org/10.1182/blood-2019-125328
Published: 2019
Journal Articles

Local Manufacture of CD19 CAR-T Cells Using an Automated Closed-System: Robust Manufacturing and High Clinical Efficacy with Low Toxicities

Olga Molostova, MD, Larisa Shelikhova, MD, Dina Schneider, PhD, Rimma Khismatullina, MD, Yakov Muzalevsky, Alexey Kazachenok, Liane Preussner, Georg Rauser, Julia Abugova, Elena Kurnikova, Dmitriy Pershin, Viktoria Zubachenko, Alexander Popov, MD PhD, Olga Illarionova, MD, Natalia Miakova, MD PhD, Dmitry Litvinov, MD, Galina Novichkova, MD PhD, Alexey A. Maschan, MD, Rimas Orentas, PhD, Boro Dropulic, PhD, Michael Maschan, MDMSc
Journal: Blood
Blood (2019) 134 (Supplement_1): 2625.
https://doi.org/10.1182/blood-2019-130370
Published: 2019
Journal Articles

Point-of-Care Manufacturing of CD20.19 Bi-Specific Chimeric Antigen Receptor T (CAR-T) Cells in a Standard Academic Cell Processing Facility for a Phase I Clinical Trial in Relapsed, Refractory NHL

Fenlu Zhu, PhD, Nirav N Shah, MD, Dina Schneider, PhD, Huiqing Xu, MD, Katherine Chaney, MS, Lawrence Luib, MS, Carolyn A. Keever-Taylor, DPhil, Boro Dropulic, PhD, Rimas Orentas, PhD, Parameswaran Hari, MBBS, MD, Bryon Johnson, PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 4553.
https://doi.org/10.1182/blood-2018-99-116566
Published: 2018
Journal Articles

A Phase 1 Study with Point-of-Care Manufacturing of Dual Targeted, Tandem Anti-CD19, Anti-CD20 Chimeric Antigen Receptor Modified T (CAR-T) Cells for Relapsed, Refractory, Non-Hodgkin Lymphoma

Nirav N Shah, MD, Fenlu Zhu, PhD, Carolyn Taylor, PhD, Dina Schneider, PhD, Winfried Krueger, Andrew Worden, Sharon Yim, Timothy S. Fenske, MD, Mehdi Hamadani, MD, Bryon Johnson, PhD, Boro Dropulic, PhD, Rimas Orentas, PhD, Parameswaran Hari, MBBS, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 4193.
https://doi.org/10.1182/blood-2018-99-110194
Published: 2018